Skip to main content

Advertisement

SpringerLink
Log in

“Sundowning” as a biological phenomenon: current understandings and future directions: an update

  • Review
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

The clinical phenomenon of early evening disruptive behavior also called “Sundowning” in elderly patients has been largely reported in the medical literature without a consistent diagnosis and criteria to define this phenomenon. The current understandings of sundowning are incomplete and current treatment strategies have relied heavily on use of antipsychotic medications, despite side effects and limited evidence to justify their use. A comprehensive understanding of the biogenesis of this phenomenon and mechanistic changes from oxidative pathways may provide novel information on completing the sundowning puzzle. Future studies could examine the utility of natural factors in reviving neuronal energy loss and altering the oxidative pathways might be safe and additional options in development of treatment models for this behavioral disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cameron DE (1941) Studies in senile nocturnal delirium. Psychiatr Q 15:47–53

    Article  Google Scholar 

  2. Khachiyants N, Trinkle D, Son SJ et al (2011) Sundown syndrome in persons with dementia: an update. Psychiatry Investig 8:275–287

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bliwise DL, Carroll JS, Lee KA et al (1993) Sleep and “sundowning” in nursing home patients with dementia. Psychiatry Res 48:277–292

    Article  CAS  PubMed  Google Scholar 

  4. Yesavage JA, Friedman L, Ancoli-Israel S et al (2003) Development of diagnostic criteria for defining sleep disturbance in Alzheimer’s disease. J Geriatr Psychiatry Neurol 16:131–139

    Article  PubMed  Google Scholar 

  5. Evans LK (1987) Sundown syndrome in institutionalized elderly. J Am Geriatr Soc 35:101–108

    Article  CAS  PubMed  Google Scholar 

  6. Gallagher-Thompson D, Brooks JO 3rd, Bliwise D, Leader J, Yesavage JA (1992) The relations among caregiver stress, “sundowning” symptoms, and cognitive decline in Alzheimer’s disease. J Am Geriatr Soc 40:807–810

    Article  CAS  PubMed  Google Scholar 

  7. Martin J, Marler M, Shochat T et al (2000) Circadian rhythms of agitation in institutionalized patients with Alzheimer’s disease. Chronobiol Int 17:405–418

    Article  CAS  PubMed  Google Scholar 

  8. Herrmann N, Lanctot KL, Sambrook R et al (2006) The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry 21:972–976

    Article  PubMed  Google Scholar 

  9. Leslie DL, Inouye SK (2011) The importance of delirium: economic and societal costs. J Am Geriatr Soc 59:S241–S243

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mahoney R, Regan C, Katona C et al (2005) Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. Am J Geriatr Psychiatry 13:795–801

    Article  PubMed  Google Scholar 

  11. Pollak CP, Perlick D (1991) Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 4:204–210

    Article  CAS  PubMed  Google Scholar 

  12. Cohen-Mansfield J (2007) Temporal patterns of agitation in dementia. Am J Geriatr Psychiatry 15:395–405

    Article  PubMed  Google Scholar 

  13. Wu Y-H, Swaab DF (2005) The human pineal gland and melatonin in aging and Alzheimer’s disease. J Pineal Res 38:145–152

    Article  CAS  PubMed  Google Scholar 

  14. Vitiello MV, Prinz PN (1989) Alzheimer’s disease. Sleep and sleep/wake patterns. Clin Geriatr Med 5:289–299

    CAS  PubMed  Google Scholar 

  15. Bliwise DL (1993) Sleep in normal aging and dementia. Sleep 16:40–81

    CAS  PubMed  Google Scholar 

  16. Horiguchi J, Yamashita H, Mizuno S et al (1999) Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol 14:33–36

    Article  CAS  PubMed  Google Scholar 

  17. Bliwise DL, Hughes M, McMahon PM et al (1995) Observed sleep/wakefulness and severity of dementia in an Alzheimer’s disease special care unit. J Gerontol A Biol Sci Med Sci 50:M303–M306

    Article  CAS  PubMed  Google Scholar 

  18. Cipriani G, Vedovello M, Nuti A et al (2011) Aggressive behavior in patients with dementia: correlates and management. Geriatr Gerontol Int 11:408–413

    Article  PubMed  Google Scholar 

  19. Zhou X, Xu J, Zhao Y (2007) Risk factors of distress in Alzheimer’s patients. Ann Acad Med Singapore 36:253–258

    PubMed  Google Scholar 

  20. Satlin A, Volicer L, Stopa EG et al (1995) Circadian locomotor activity and core-body temperature rhythms in Alzheimer’s disease. Neurobiol Aging 16:765–771

  21. Volicer L, Harper DG, Manning BC et al (2001) Sundowning and circadian rhythms in Alzheimer’s disease. Am J Psychiatry 158:704–711

    Article  CAS  PubMed  Google Scholar 

  22. Steinman MA, Landefeld CS, Rosenthal GE et al (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54:1516–1523

    Article  PubMed  Google Scholar 

  23. Gallagher P, Barry P, O’Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32:113–121

    Article  CAS  PubMed  Google Scholar 

  24. Berryman SN, Jennings J, Ragsdale S et al (2012) Beers criteria for potentially inappropriate medication use in older adults. Medsurg Nurs 21:129–132 (quiz 133)

    PubMed  Google Scholar 

  25. Blanco-Reina E, Ariza-Zafra G, Ocana-Riola R et al (2012) American geriatrics society beers criteria: enhanced applicability for detecting potentially inappropriate medications in european older adults? A comparison with the screening tool of older person’s potentially inappropriate prescriptions. J Am Geriatr Soc 62:1217–1223

    Article  Google Scholar 

  26. Burkhardt H, Gladisch R (2003) Pharmacotherapy of elderly patients from the clinical viewpoint. Internist (Berl) 44:959–967

    Article  CAS  Google Scholar 

  27. Gill SS, Mamdani M, Naglie G et al (2005) A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 165:808–813

    Article  PubMed  Google Scholar 

  28. Salazar JA, Poon I, Nair M (2007) Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 6:695–704

    Article  PubMed  Google Scholar 

  29. Falsetti AE (2000) Risperidone for control of agitation in dementia patients. Am J Health Syst Pharm 57:862–870

    CAS  PubMed  Google Scholar 

  30. McGaffigan S, Bliwise DL (1997) The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies. Drugs Aging 10:10–17

    Article  CAS  PubMed  Google Scholar 

  31. Bliwise DL, Watts RL, Watts N et al (1995) Disruptive nocturnal behavior in Parkinson’s disease and Alzheimer’s disease. J Geriatr Psychiatry Neurol 8:107–110

    Article  CAS  PubMed  Google Scholar 

  32. Fernandez Martinez M, Castro Flores J, Perez de las HZ et al (2008) Prevalence of neuropsychiatric symptoms in elderly patients with dementia in Mungialde County (Basque Country, Spain). Dement Geriatr Cogn Disord 25:103–108

    Article  PubMed  Google Scholar 

  33. Fiedorowicz JG, He J, Merikangas KR (2011) The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res 70:145–154

    Article  PubMed  PubMed Central  Google Scholar 

  34. Henderson R, Kurlan R, Kersun JM et al (1992) Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4:257–264

    Article  CAS  PubMed  Google Scholar 

  35. Maes M, Yirmyia R, Noraberg J et al (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24:27–53

    Article  CAS  PubMed  Google Scholar 

  36. Bachman D, Rabins P (2006) “Sundowning” and other temporally associated agitation states in dementia patients. Annu Rev Med 57:499–511

    Article  CAS  PubMed  Google Scholar 

  37. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127

    Article  CAS  PubMed  Google Scholar 

  38. Bozner P, Grishko V, LeDoux SP et al (1997) The amyloid beta protein induces oxidative damage of mitochondrial DNA. J Neuropathol Exp Neurol 56:1356–1362

    Article  CAS  PubMed  Google Scholar 

  39. Seligman MEP (1972) Learned helplessness. Annu Rev Med 23:407–412

    Article  CAS  PubMed  Google Scholar 

  40. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525–534

    Article  CAS  PubMed  Google Scholar 

  41. Lemaire V, Koehl M, Le Moal M et al (2000) Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 97:11032–11037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Luine V, Villegas M, Martinez C et al (1994) Repeated stress causes reversible impairments of spatial memory performance. Brain Res 639:167–170

    Article  CAS  PubMed  Google Scholar 

  43. Bedrosian TA, Herring KL, Weil ZM et al (2011) Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice. Proc Natl Acad Sci USA 108:11686–11691

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Sterniczuk R, Dyck RH, Laferla FM et al (2010) Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: part 1. Circadian changes. Brain Res 1348:139–148

    Article  CAS  PubMed  Google Scholar 

  45. Vloeberghs E, Van Dam D, Engelborghs S et al (2004) Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. Eur J Neurosci 20:2757–2766

    Article  PubMed  Google Scholar 

  46. Das A, Rai D, Dikshit M et al (2005) Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats. Life Sci 77:2299–2311

    Article  CAS  PubMed  Google Scholar 

  47. Friedman L, Brooks JO 3rd, Bliwise DL et al (1995) Perceptions of life stress and chronic insomnia in older adults. Psychol Aging 10:352–357

    Article  CAS  PubMed  Google Scholar 

  48. Kryger M, Monjan A, Bliwise D et al (2004) Sleep, health, and aging. Bridging the gap between science and clinical practice. Geriatrics 59:24–26, 29–30

  49. Allison SP, Lobo DN (2004) Fluid and electrolytes in the elderly. Curr Opin Clin Nutr Metab Care 7:27–33

    Article  PubMed  Google Scholar 

  50. Bales CW, Ritchie CS (2002) Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu Rev Nutr 22:309–323

    Article  CAS  PubMed  Google Scholar 

  51. Abbasi AA, Rudman D (1993) Observations on the prevalence of protein-calorie undernutrition in VA nursing homes. J Am Geriatr Soc 41:117–121

    Article  CAS  PubMed  Google Scholar 

  52. Bozzetti F (2003) Nutritional issues in the care of the elderly patient. Crit Rev Oncol Hematol 48:113–121

  53. Chernoff R (2004) Protein and older adults. J Am Coll Nutr 23:627S–630S

  54. Chidester JC, Spangler AA (1997) Fluid intake in the institutionalized elderly. J Am Diet Assoc 97:23–28 (quiz 29–30)

    Article  CAS  PubMed  Google Scholar 

  55. Deijen JB, Slump E, Wouters-Wesseling W et al (2003) Nutritional intake and daily functioning of psychogeriatric nursing home residents. J Nutr Health Aging 7:242–246

    CAS  PubMed  Google Scholar 

  56. De La Torre JC (2008) Pathophysiology of neuronal energy crisis in Alzheimer’s disease. Neurodegener Dis 5:126–132

    Article  PubMed  Google Scholar 

  57. Kuloglu M, Atmaca M, Tezcan E et al (2002) Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive–compulsive disorder. Neuropsychobiology 46:27–32

    Article  CAS  PubMed  Google Scholar 

  58. Hu X, Weng Z, Chu CT et al (2011) Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 31:247–261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Erecinska M, Silver IA (2001) Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 128:263–276

    Article  CAS  PubMed  Google Scholar 

  60. Gu H, Tang C, Peng K et al (2009) Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice. J Biomed Biotechnol 2009:613879

    Article  PubMed  PubMed Central  Google Scholar 

  61. Maes M, Kubera M, Obuchowiczwa E et al (2011) Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 32:7–24

    CAS  PubMed  Google Scholar 

  62. Campbell S, Marriott M, Nahmias C et al (2004) Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161:598–607

    Article  PubMed  Google Scholar 

  63. Brown ES, Woolston DJ, Frol A et al (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55:538–545

    Article  CAS  PubMed  Google Scholar 

  64. Fournier NM, Duman RS (2011) Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res 227:440–449

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kim GS, Jung JE, Narasimhan P et al (2012) Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice. Neurobiol Dis 46:440–449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Maes M, Kubera M, Obuchowiczwa E et al (2011) Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 32:7–24

    CAS  PubMed  Google Scholar 

  67. Greve M, O’Connor D (2005) A survey of Australian and New Zealand old age psychiatrists’ preferred medications to treat behavioral and psychological symptoms of dementia (BPSD). Int Psychogeriatr 17:195–205

    Article  PubMed  Google Scholar 

  68. Singer C, Tractenberg RE, Kaye J et al (2003) A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 26:893–901

    PubMed  PubMed Central  Google Scholar 

  69. Cardinali DP, Furio AM, Brusco LI (2010) Clinical aspects of melatonin intervention in Alzheimer’s disease progression. Curr Neuropharmacol 8:218–227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. de Jonghe A, Korevaar JC, van Munster BC et al (2010) Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. Int J Geriatr Psychiatry 25:1201–1208

    Article  PubMed  Google Scholar 

  71. Skjerve A, Nygaard HA (2000) Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int J Geriatr Psychiatry 15:1147–1151

    Article  CAS  PubMed  Google Scholar 

  72. Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E (2001) A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology 57:613–620

    Article  CAS  PubMed  Google Scholar 

  73. Katz IR, Jeste DV, Mintzer JE et al (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 60:107–115

    Article  CAS  PubMed  Google Scholar 

  74. Street JS, Clark WS, Kadam DL et al (2001) Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer’s dementia. Int J Geriatr Psychiatry 16:S62–S70

    Article  PubMed  Google Scholar 

  75. Villanyi D, Fok M, Wong RY (2011) Medication reconciliation: identifying medication discrepancies in acutely ill hospitalized older adults. Am J Geriatr Pharmacother 9:339–344

    Article  PubMed  Google Scholar 

  76. Hines LE, Murphy JE (2011) Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9:364–377

    Article  CAS  PubMed  Google Scholar 

  77. Huisman-Baron M, van der Veen L, Jansen PA et al (2011) Criteria for drug selection in frail elderly persons. Drugs Aging 28:391–402

    Article  PubMed  Google Scholar 

  78. Inouye SK (2000) Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med 32:257–263

    Article  CAS  PubMed  Google Scholar 

  79. Inouye SK, Bogardus ST Jr, Baker DI et al (2000) The hospital elder life program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital elder life program. J Am Geriatr Soc 48:1697–1706

    Article  CAS  PubMed  Google Scholar 

  80. Fox MT, Sidani S, Persaud M et al (2013) Acute care for elders components of acute geriatric unit care: systematic descriptive review. J Am Geriatr Soc 61:939–946

    Article  PubMed  Google Scholar 

  81. Ancoli-Israel S, Martin JL, Gehrman P et al (2003) Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 11:194–203

    Article  PubMed  Google Scholar 

  82. Ancoli-Israel S, Gehrman P, Martin JL et al (2003) Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med 1:22–36

    Article  PubMed  Google Scholar 

  83. Van Someren EJ, Kessler A, Mirmiran M et al (1997) Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 41:955–963

    Article  PubMed  Google Scholar 

  84. Fontana Gasio P, Krauchi K, Cajochen C et al (2003) Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol 38:207–216

    Article  PubMed  Google Scholar 

  85. Omkar SN, Mour M, Das D (2011) A mathematical model of effects on specific joints during practice of the Sun Salutation–a sequence of yoga postures. J Bodyw Mov Ther 15:201–208

    Article  CAS  PubMed  Google Scholar 

  86. Lubart R, Lavi R, Friedmann H et al (2006) Photochemistry and photobiology of light absorption by living cells. Photomed Laser Surg 24:179–185

    Article  CAS  PubMed  Google Scholar 

  87. Rubio CR, Simes JC, Moya M et al (2009) Inflammatory and oxidative stress markers in experimental crystalopathy: their modification by photostimulation. Photomed Laser Surg 27:79–84

    Article  PubMed  Google Scholar 

  88. Yu W, Naim JO, McGowan M et al (1997) Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol 66:866–871

    Article  CAS  PubMed  Google Scholar 

  89. Gammack JK, Burke JM (2009) Natural light exposure improves subjective sleep quality in nursing home residents. J Am Med Dir Assoc 10:440–441

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Geriatrics and Palliative Care, Department of Internal Medicine, The University Hospitals Case Medical Center, Cleveland, OH, 44131, USA

    Gowrishankar Gnanasekaran

Authors
  1. Gowrishankar Gnanasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gowrishankar Gnanasekaran.

Ethics declarations

Conflict of interest

Author has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gnanasekaran, G. “Sundowning” as a biological phenomenon: current understandings and future directions: an update. Aging Clin Exp Res 28, 383–392 (2016). https://doi.org/10.1007/s40520-015-0431-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-015-0431-3

Keywords

Search

Navigation